Free Trial

Petros Pharmaceuticals (PTPI) SEC Filings & 10K Form

Petros Pharmaceuticals logo
$0.29 -0.02 (-5.67%)
(As of 12/20/2024 05:31 PM ET)

Recent Petros Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/16/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
3:57 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:21 PM
Petros Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:11 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
10:14 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
10/25/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form DEF 14A
10/25/2024
4:02 PM
Petros Pharmaceuticals (Filer)
Form ARS
10/18/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:07 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:19 PM
Petros Pharmaceuticals (Filer)
Form PRE 14A
10/04/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
05/15/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/01/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM
Ayrton Capital LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G
02/06/2024
9:23 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
01/12/2024
3:32 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
4:05 PM
Bradley Greg (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:06 PM
Petros Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:06 PM
Arnold Mitchell (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:07 PM
Petros Pharmaceuticals (Issuer)
WALKER WAYNE REMELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:07 PM
Boctor Fady (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:08 PM
Bernstein Bruce (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTPI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners